GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zentiva SA (BSE:SCD) » Definitions » Ending Cash Position

Zentiva (BSE:SCD) Ending Cash Position : lei34 Mil (As of Dec. 2024)


View and export this data going back to 1998. Start your Free Trial

What is Zentiva Ending Cash Position?

Zentiva's Ending Cash Position for the quarter that ended in Dec. 2024 was lei34 Mil.

Zentiva's quarterly Ending Cash Position declined from Jun. 2024 (lei35 Mil) to Sep. 2024 (lei24 Mil) but then increased from Sep. 2024 (lei24 Mil) to Dec. 2024 (lei34 Mil).

Zentiva's annual Ending Cash Position increased from Dec. 2022 (lei11 Mil) to Dec. 2023 (lei27 Mil) and increased from Dec. 2023 (lei27 Mil) to Dec. 2024 (lei34 Mil).

Zentiva Ending Cash Position Historical Data

The historical data trend for Zentiva's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zentiva Ending Cash Position Chart

Zentiva Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 406.71 62.60 11.19 27.30 33.63

Zentiva Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.30 30.56 34.89 23.61 33.63

Zentiva Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Zentiva's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=27.303+6.322
=34

Zentiva's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=23.606+10.019
=34

Zentiva Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Zentiva's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Zentiva Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zentiva SA (BSE:SCD) » Definitions » Ending Cash Position
Comparable Companies
BSE:ATB BSE:BIO ZTS XTER:MRK NSE:SUNPHARMA LSE:HLN TSE:4502 XSWX:GALD XTAE:TEVA NSE:DIVISLAB XSWX:SDZ VTRS SZSE:000538 NBIX BOM:543904 BOM:500124 NSE:TORNTPHARM HKSE:03692 TSE:4507 BOM:500257
Traded in Other Exchanges
N/A
Address
No. 50, Theodor Pallady Boulevard, Sector 3, Bucharest, ROU, 032266
Website
https://www.zentiva.ro
Zentiva SA is a Romania-based producer of medicines on the local market. The product portfolio of Zentiva SA includes more than 126 products for human use, such as solids (tablets, capsules, and pellets), generic products, and injectable solutions. The company provides products for therapeutic areas such as Cardiovascular diseases, Anti-inflammatory and pain-relieving medications, urologists, Blood diseases, Gastrointestinal and metabolic disorders, Central nervous system, Medicines against infections, and Diseases of the respiratory system.